Cencora (COR) return on invested capital (ROIC)

Return on invested capital · fiscal 2025
56.7%

Cencora (COR) earned a return on invested capital of 56.7% in fiscal 2025 (the year ended September 30, 2025). That is 69.1 percentage points lower than the 125.9% of fiscal 2024. Figures as of 17 Nov 2026, 22:20 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on invested capital, fiscal 2025
56.7%
Change on fiscal 2024
−69.1 pts
Highest on record
125.9%fiscal 2024
Lowest on record
56.7%fiscal 2025
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Cencora return on invested capital (ROIC), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was 125.9% in fiscal 2024 and the lowest 56.7% in fiscal 2025. The fiscal 2025 figure is no higher than in any of the 3 earlier fiscal years on record, whose median is 99.9%.

History · 4 fiscal years

Return on invested capital by fiscal year

Cencora return on invested capital (ROIC), year by year

Cencora (COR) return on invested capital (ROIC) by fiscal year
Fiscal yearReturn on invested capitalChangeYear ended
202556.7% 69.1 pts down
2024125.9% 46.6 pts up
202379.2% 20.7 pts down
202299.9%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

How to read it

It measures how well the business turns capital into profit whoever supplied it; a figure above the cost of that capital, roughly 8–10%, means growth creates value.

Return on invested capital at health care companies of similar size

Return on invested capital of Cencora and comparable companies
CompanyReturn on invested capitalFiscal year
Takeda Pharmaceutical TAK3.1%2026
Cencora COR56.7%2025
Boston Scientific BSX10.1%2025
Cardinal Health CAH217.0%2026
argenx ARGX36.0%2025
Edwards Lifesciences EW19.9%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on COR

Cencora, figure by figure

Cencora (COR) overview: price, valuation and scorecardAll health care companies by market value

Cencora return on invested capital (ROIC): questions and answers

What is Cencora's return on invested capital?

Cencora (COR) earned a return on invested capital of 56.7% in fiscal 2025 (the year ended September 30, 2025). That is 69.1 percentage points lower than the 125.9% of fiscal 2024.

Is Cencora's return on invested capital high or low compared with its own history?

The fiscal 2025 figure is no higher than in any of the 3 earlier fiscal years on record, whose median is 99.9%.

What are the highest and lowest return on invested capital figures on record for Cencora?

Across the 4 fiscal years on record (2022–2025), the highest was 125.9% in fiscal 2024 and the lowest 56.7% in fiscal 2025.

How is Cencora's return on invested capital calculated?

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cencora (COR) return on invested capital (ROIC)”, data as of 17 November 2026. https://funkfolio.com/stock/COR/roic

Underlying data: the company's filings with the SEC and Yahoo Finance.